Ibuprofen Covid-19 Warning May Be Premature
On Tuesday, the World Health Organization announced it is recommending that people with COVID-19 symptoms avoid taking the anti-inflammatory drug ibuprofen. U.S. officials and physicians responded with skepticism and today, WHO reversed its decision.
 
Important Conversations: Anxiety Management and Wellness
As coronavirus moves its way across the country, Dr. Kim Gorgens recommends that rheumatologists proactively reach out to their patients to address concerns that may lead to stress and ill-advised changes in treatment regimens, such as stopping treatments without consulting a physician.
 
COVID-19 Rheumatology Registry Underway
Dr. Philip Robinson, a rheumatologist in Brisbane, Australia, is in the process of creating an international registry that will include information about COVID-19 specifically for patients with rheumatic disease, in particular, those receiving immunosuppressive therapies.
 
Visit Rheumatology Network for easy access to new job opportunities in rheumatology. As a service to our readers, we've posted a national "Job Board" in the upper right-hand corner of the site. Suggestions for other content sections? Email the editor at areyes@mmhgroup.com.